Fiber Pro+
Natural health product licensed in Canada
- Licence holder
- Isagenix Canada ULC
- NPN or DIN-HM
- 80066630
- Status
- Inactive licence
- Licence date
- 27 January 2016
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Inuline Source : Inuline | 2 g | Not calculated |
| Maltodextrine Source : Maltodextrin | 3 g | Not calculated |
| Oryza sativa Source : Oryza sativa - Graine | 50 mg | Not calculated |
Non-medicinal ingredients
Feuille de Stevia rebaudiana, Jus de canne à sucre évaporé, Saveur, Poudre de jus d'orange, Acide citrique anhydre
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 packet | 1 Tous les jours |
| Adultes | minimum: 19 years | 1 Mesures | 1 Tous les jours |
Uses authorised in Canada
Source of fiber for the maintenance of good health. Helps support and maintain a healthy digestive system. Helps provide gentle relief of constipation and/or irregularity.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If symptoms worsen or if laxative effect does not occur within seven days, consult a health care practitioner. If you are taking medications which inhibit peristaltic movement, consult a health care practitioner prior to use. If you have symptoms such as abdominal pain, nausea, vomiting or fever, consult a health care practitioner prior to use. If you are experiencing a sudden change in bowel habits that has persisted for more than 2 weeks, undiagnosed rectal bleeding, or have failed to defecate following the use of a laxative product, consult a health care practitioner prior to use.
- Effets indésirables connus
Hypersensitivity has been known to occur.
Source
Official Health Canada record, licence 80066630
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.